The GLP-1 receptor in airway inflammation in asthma: a promising novel target?
Ashley Y. Wu, R. Stokes Peebles
Abstract
In the last two decades, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as promising therapeutics for diabetes mellitus, a disease with increasing global burden – 34 million in the ...
Topics & Concepts
MedicineAsthmaInflammationGlucagon-like peptide 1 receptorGlucagon-like peptide-1ReceptorImmunologyDiabetes mellitusCOPDB2 receptorInternal medicineAgonistType 2 diabetesEndocrinologyBradykininDiabetes Treatment and ManagementAsthma and respiratory diseasesHelicobacter pylori-related gastroenterology studies